Free Trial

Relay Therapeutics (RLAY) SEC Filings & 10K Form

Relay Therapeutics logo
$3.29 -0.04 (-1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$3.29 0.00 (0.00%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Relay Therapeutics SEC Filings

DateFilerForm TypeView
04/30/2025
7:23 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:24 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:24 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:25 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
3:10 PM
Relay Therapeutics (Filer)
Form DEFA14A
04/23/2025
3:15 PM
Relay Therapeutics (Filer)
Form ARS
04/23/2025
3:05 PM
Relay Therapeutics (Filer)
Form DEF 14A
03/20/2025
5:13 PM
Point72 Asset Management, L.P. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G
02/26/2025
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:56 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G/A
01/30/2025
8:02 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:06 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:10 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:16 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:01 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:03 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
3:04 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
8:00 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:30 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:35 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:01 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:18 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:07 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:08 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:45 PM
Relay Therapeutics (Filer)
Form 424B5
09/11/2024
3:49 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:43 PM
Relay Therapeutics (Filer)
Form 424B5
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
09/09/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:23 PM
Relay Therapeutics (Filer)
Form S-3ASR
08/06/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:42 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:06 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:37 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:24 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:29 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:47 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:05 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:15 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:38 PM
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:18 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:01 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:02 PM
HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Relay Therapeutics (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:12 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RLAY) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners